Sort
15,842 grants matching “pancreatic cancer”
Biochemical, molecular, and dietary studies for pancreatic cancer within PLCO
$449,703Rachael Solomon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
Indiana University (IU) Clinical Center for Chronic Pancreatitis Clinical Research Network
$449,679Evan L Fogel · Indiana University Indianapolis · U01 · FY2022 · DK
Statistical methods to delineate the spatial and temporal pattern of cell-cell interactions in Spatial Transcriptomics data
$449,625Ziyi Li · University Of Tx Md Anderson Can Ctr · R35 · FY2025 · GM
Targeting HNF1A-mediated therapeutic resistance in pancreatic ductal adenocarcinoma
$449,607Ethan Vincent Abel · Roswell Park Cancer Institute Corp · R37 · FY2024 · CA
Multifunctional Nanoassemblies for Ligand-directed Imaging and Therapy of Endocri
$449,283Wadih Arap · University Of Texas Hlth Sci Ctr Houston · U54 · FY2013 · CA
Cell Growth Signaling in Cancer Development
$449,231David M Sabatini · Whitehead Institute For Biomedical Res · R01 · FY2019 · CA
Preclinical Development of First-in-Class NDUFS7 Antagonists for the Treatment of Pancreatic Cancer
$449,119Nouri Neamati · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Combination Therapy for Pancreatic Cancer
$448,992Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
OVERCOMING STROMAL BARRIERS TO THERAPEUTICS IN PANCREAS CANCER
$448,893Sunil R Hingorani · University Of Nebraska Medical Center · R01 · FY2024 · CA
STAT3 is a Critical Regulator of Tumor Cell Plasticity
$448,729Nancy C. Reich · State University New York Stony Brook · R01 · FY2021 · CA
STAT3 is a Critical Regulator of Tumor Cell Plasticity
$448,729Nancy C. Reich · State University New York Stony Brook · R01 · FY2019 · CA
STAT3 is a Critical Regulator of Tumor Cell Plasticity
$448,729Nancy C. Reich · State University New York Stony Brook · R01 · FY2020 · CA
The development of Saccharomyces (yeast) vaccines for cancer therapy
$448,659James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Universal Internal Standard for Reproducible Accurate Quantification of Exosome Protein Markers
$448,610David M. Lubman · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$448,604Lily Yang · Emory University · R01 · FY2024 · CA
Understanding and improving novel oncolytic viruses for pancreatic cancer
$448,536Valery Zurabovich Grdzelishvili · University Of North Carolina Charlotte · R15 · FY2024 · CA
Project 1: Targeting autophagy for the treatment of KRAS-mutant PDAC
$448,515Channing J Der · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Defining the Role of Tumor-Neural Crosstalk in head and Neck Cancer Progression and Treatment Resistance
$448,510Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
Role of immune cells in chronic pancreatitis
$448,494Aida Habtezion · Stanford University · R01 · FY2020 · DK
Metarrestin for the Treatment of Pancreatic Cancer
$448,357Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Transport Oncophysics Core
$448,357Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA
Epigenetic Drivers of Cancer Progression
$448,307Andrew P Feinberg · Johns Hopkins University · R01 · FY2013 · CA
Development of therapeutic bacteriophages against carbapenemase-resistant Klebsiella pneumoniae
$448,294Jason J. Gill · Texas A&M Agrilife Research · R33 · FY2020 · AI
Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers
$448,091Stuart Duncan Ibsen · Oregon Health & Science University · R37 · FY2024 · CA
Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors
$448,088Melissa L Fishel · Indiana University Indianapolis · R01 · FY2021 · CA